✦ LIBER ✦

Cellular therapies in motor neuron diseases

✍ Scribed by Mamatha S. Nayak; Yun-Sook Kim; Michelle Goldman; Hans S. Keirstead; Douglas A. Kerr

Book ID: 116270486
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 258 KB
Volume: 1762
Category: Article
ISSN: 0925-4439
DOI: 10.1016/j.bbadis.2006.06.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Motor neuron diseases

📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 348 KB

W11.1 Motor neuron diseases

✍ M. de Carvalho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Central motor delay in the motor neuron

Central motor delay in the motor neuron diseases

✍ George A. Small; Seth Pullman; Ronald Emerson; Dale J. Lange 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Gene therapy for motor neuron disease

✍ Sendtner, Michael 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 224 KB

110. 3,4-Aminopyridine in motor neuron d

110. 3,4-Aminopyridine in motor neuron diseases

✍ H. Rashed; M. Zeno; B. Tolly; M. Igarashi; D. Li 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Acetylcholinesterase and ATPases in moto

Acetylcholinesterase and ATPases in motor neuron degenerative diseases

✍ Dr. C. G. Rasool; Dr. D. Chad; Dr. W. G. Bradley; B. Connolly; Dr. J. K. Baruah 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 832 KB

Acetylcholinesterase (AChE) activity was measured in the presence of the specific inhibitor of pseudocholinesterase, iso-OMPA, in plasma from patients with amyotrophic lateral sclerosis (ALS), progressive muscular atrophy (PMA), neuromuscular disease controls, and normal controls. Both AChE and Na-K